| 26.10.2023 07:00 | GSK | NMPA approves Vocabria+Rekambys in China | RNS |
| 25.10.2023 16:01 | WEIR, NXT, GSK | UK earnings, trading statements calendar - next 7 days | Alliance |
| 25.10.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 25.10.2023 09:35 | GSK | GSK says RSV jab shows promising response in adults aged 50 to 59 | Alliance |
| 25.10.2023 07:00 | GSK | New data for Arexvy, GSK’s RSV vaccine | RNS |
| 20.10.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 18.10.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 17.10.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 16.10.2023 08:09 | GSK | TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer | Alliance |
| 16.10.2023 07:00 | GSK | Jemperli plus chemotherapy positive CHMP opinion | RNS |
| 13.10.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 12.10.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 11.10.2023 09:17 | AIBG, BIRG, CAML | LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya | Alliance |
| 11.10.2023 08:36 | GSK | TOP NEWS: GSK reaches settlement for Zantac litigation in California | Alliance |
| 11.10.2023 07:00 | GSK | Zantac (ranitidine) litigation | RNS |
| 10.10.2023 11:00 | GSK, HLN | Holding(s) in Company | RNS |
| 09.10.2023 08:16 | GSK | TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine | Alliance |
| 09.10.2023 07:00 | GSK | GSK and Zhifei announce vaccine partnership | RNS |
| 06.10.2023 07:57 | HLN, GSK | UPDATE: GSK banks GBP886 million from Haleon share sale | Alliance |
| 06.10.2023 07:00 | GSK | GSK completes sale of shares in Haleon plc | RNS |
| 05.10.2023 16:46 | GSK | GSK announces intention to sell shares in Haleon | RNS |
| 05.10.2023 15:47 | XPP, WPP, TTG | UK dividends calendar - next 7 days | Alliance |
| 03.10.2023 18:19 | GSK | IN BRIEF: GSK's Jemperli approved in UK for endometrial cancer | Alliance |
| 02.10.2023 15:00 | GSK | Total Voting Rights | RNS |
| 27.09.2023 15:00 | GSK | Directorate Change | RNS |
| 25.09.2023 09:13 | ASLI, IHR, WHR | LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy' | Alliance |
| 25.09.2023 08:37 | GSK | TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan | Alliance |
| 25.09.2023 07:00 | GSK | GSK RSV vaccine for older adults approved in Japan | RNS |
| 21.09.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 19.09.2023 09:30 | GSK | GSK says new HIV PrEP medication authorised by European Commission | Alliance |
| 19.09.2023 07:00 | GSK | Apretude for PrEP receives EMA approval | RNS |
| 18.09.2023 09:40 | BPCR, FEVR, SFOR | LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS | Alliance |
| 18.09.2023 07:00 | GSK | FDA approves Ojjaara (momelotinib) | RNS |
| 15.09.2023 21:52 | GSK | GSK's Ojjaara approved in US for myelofibrosis patients with anaemia | Alliance |
| 13.09.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 11.09.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 11.09.2023 08:24 | GSK | Japan accepts GSK's regulatory filing for momelotinib for blood cancer | Alliance |
| 11.09.2023 07:00 | GSK | Momelotinib filing accepted in Japan | RNS |
| 06.09.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 06.09.2023 09:32 | CORD, ASC, AMS | LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords | Alliance |
| 04.09.2023 06:00 | GSK | More UK babies to need hospital treatment over delay of GSK's RSV jab | Alliance |
| 01.09.2023 15:00 | GSK | Total Voting Rights | RNS |
| 01.09.2023 09:11 | GSK | GSK antibody accepted for Japan review, Goldman Sachs reduces stake | Alliance |
| 01.09.2023 07:00 | GSK | GSK’s Nucala CRSwNP submission accepted in Japan | RNS |
| 31.08.2023 15:16 | GSK | Holding(s) in Company | RNS |
| 31.08.2023 15:14 | GSK | Holding(s) in Company | RNS |
| 25.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 23.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 23.08.2023 08:17 | GSK | GSK gets positive results from shingles trial of Shingrix in China | Alliance |
| 23.08.2023 07:00 | GSK | Shingrix data demonstrate 100% efficacy in China | RNS |
| 22.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 17.08.2023 19:53 | GSK | Charity says HIV drug deal with GSK's ViiV on ice over price secrecy | Alliance |
| 10.08.2023 15:46 | SRE, SDR, SBRE | UK dividends calendar - next 7 days | Alliance |
| 10.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 09.08.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 08.08.2023 13:05 | GSK | Publication of Base Prospectus | RNS |
| 07.08.2023 08:12 | GSK, HLN | PRESS: Inflexion among firms looking to buy Haleon's nicotine business | Alliance |
| 02.08.2023 20:45 | GSK | TOP NEWS: GSK sues Pfizer over patent infingements for RSV vaccine | Alliance |
| 02.08.2023 08:23 | GSK, HLN | TOP NEWS: Haleon boosts annual guidance after solid first half | Alliance |
| 01.08.2023 15:00 | GSK | Total Voting Rights | RNS |
| 31.07.2023 19:42 | GSK | IN BRIEF: GSK hails US FDA approval for cancer treatment, Jemperli | Alliance |
| 31.07.2023 18:00 | GSK | FDA approves new use for Jemperli plus chemo | RNS |
| 31.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 31.07.2023 12:21 | GSK, OCI, TSCO | DIRECTOR DEALINGS: Qinetiq, Tesco and GSK executives sell shares | Alliance |
| 31.07.2023 09:16 | IAG, RKT, FRAS | LONDON BROKER RATINGS: Oddo BHF raises IAG to 'outperform' | Alliance |
| 28.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 26.07.2023 09:28 | GSK | TOP NEWS: GSK raises annual guidance on quarterly earnings growth | Alliance |
| 26.07.2023 07:00 | GSK | 2nd Quarter Results | RNS |
| 24.07.2023 08:25 | GSK | GSK says HIV prevention drug recommended for marketing in Europe | Alliance |
| 24.07.2023 07:00 | GSK | Cabotegravir LA for PrEP receives positive CHMP | RNS |
| 20.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 17.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 14.07.2023 09:13 | SFOR, BHP, HOC | LONDON BROKER RATINGS: HSBC says 'buy' AstraZeneca but 'reduce' GSK | Alliance |
| 13.07.2023 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 10.07.2023 09:27 | CNE, ENQ, JSE | LONDON BROKER RATINGS: HSBC downgrades commercial property stocks | Alliance |
